End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
284,000 KRW | +0.89% | -3.40% | -19.43% |
May. 16 | Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.43% | 2.64B | |
+19.11% | 43.32B | |
+20.38% | 22.81B | |
+17.44% | 15.32B | |
+22.68% | 14.91B | |
+58.52% | 13.23B | |
-0.05% | 6.79B | |
-15.60% | 6.51B | |
-8.87% | 5.73B | |
+12.39% | 5.53B |
- Stock Market
- Equities
- A128940 Stock
- News Hanmi Pharm. Co., Ltd.
- Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8%